| Code | Description | Claims | Beneficiaries | Total Paid |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,490 |
5,130 |
$1.18M |
| J9035 |
Injection, bevacizumab, 10 mg |
3,028 |
2,876 |
$297K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,567 |
7,413 |
$202K |
| 92134 |
|
9,942 |
9,525 |
$199K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
76 |
76 |
$91K |
| 92235 |
|
1,504 |
1,496 |
$90K |
| 92250 |
|
1,967 |
1,942 |
$57K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
843 |
835 |
$33K |
| J0178 |
Injection, aflibercept, 1 mg |
25 |
25 |
$23K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
715 |
711 |
$20K |
| 92226 |
|
774 |
391 |
$20K |
| 92225 |
|
585 |
303 |
$16K |
| J7999 |
Compounded drug, not otherwise classified |
1,568 |
1,541 |
$10K |
| 67210 |
|
12 |
12 |
$4K |
| 92083 |
|
37 |
37 |
$862.95 |
| 92133 |
|
33 |
33 |
$566.02 |